Epilepsy Flashcards
1
Q
Differential diagnosis of epilpesy
A
- syncope
- transient ischaemic attacks
- REM sleep disorder
- migraine
- hypoglycaemia
- pyschogenic epsiodes
2
Q
Causes of epilepsy
A
- idiopathic- no obvious pathology/ most common
- brain tumour
- alcohol
- autoimmune condition- can cause localised encephalitis
- brain injury/ trauma- provides an epileptic focus which persists long after the injury has healed
- infections- inflammation provides an epileptic focus
3
Q
Common factors lowering seizure threshold
A
- sleep deprivation
- alcohol withdrawal
- television flicker
- epileptogenic drugs
- head trauma
- systemic infection
- recreational drugs
- menstruation
4
Q
Occasional factors lowering seizure threshold
A
- dehydration
- barbiturate withdrawal
- benzodiazepine withdrawal
- hyperventilation
- flashing lights
- diet and missed meals
- stress
- intense exercise
5
Q
Ideal AED
A
- low risk of interaction
- low protein binding
- long elimination half life
- linear kinetics
- complete absorption
6
Q
Established AED’s
A
- phenytoin
- phenobarbitone
- primidone
- carbamazepine
- ethosuximide
- clonazepam
- clobazam
- sodium valproate
7
Q
Newer AED’s
A
- gabapentin
- pregablin
- lacosamide
- topiramate
- lamotrigine
8
Q
Risks of sodium valproate
A
- high risk of serious developmental disorders
- congenital malformations
9
Q
patient education of sodium valproate
A
- risks associated
- need to use effective contraception
- need for regular review for treatment
- the need to rapidly consult if she is planning a pregnancy or becomes pregnant
10
Q
what AED’s can worsen absence seizures?
A
carbamazepine and phenytoin
11
Q
what seizure type does ethosuximide have efficacy against
A
- absence seizures but not others
12
Q
phenytoin kinetics
A
- zero order kinetics
- small therapeutic window
- highly protein bound
13
Q
carbamazepine
A
- induces its own metabolism at initiation
- repeated dosing reduces half life to 1/3
- metabolism is readily induced by drugs that induce hepatic microsomal enzymes
- use of slow release formulations can reduce peak concentrations and improve tolerance